DICER1 and chronic myelogenous leukemia, BCR-ABL1 positive: This variant is thought to alter the interaction of miRNAs or RNA‐binding proteins with DICER1 transcripts, potentially affecting the hDicer protein level and global miRNA expression, which may drive CML pathogenesis [92].